Nuveen
BVS icon

Nuveen’s Bioventus BVS Stock Holding History

Nuveen’s Portfolio BVS Stock Details BVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.6M Buy
169,513
+20,851
+14% +$199K ﹤0.01% 2695
2026
Q1 		$1.36M Buy
148,662
+1,411
+1% +$11.8K ﹤0.01% 2426
2025
Q4 		$1.1M Hold
147,251
– – ﹤0.01% 2576
2025
Q3 		$985K Sell
147,251
-39,007
-21% -$271K ﹤0.01% 2630
2025
Q2 		$1.23M Sell
186,258
-327,366
-64% -$2.32M ﹤0.01% 2514
2025
Q1 		$21.3M Sell
513,624
-268,513
-34% -$2.68M 0.01% 1094
2024
Q4 		$8.21M Buy
782,137
+135,236
+21% +$1.6M ﹤0.01% 1697
2024
Q3 		$7.73M Buy
646,901
+532,302
+464% +$4.6M ﹤0.01% 1762
2024
Q2 		$659K Buy
+114,599
New +$629K ﹤0.01% 2897
2022
Q4 		– Sell
-106,134
Closed -$743K – 3193
2022
Q3 		$743K Sell
106,134
-2,416
-2% -$18.9K ﹤0.01% 2855
2022
Q2 		$740K Buy
108,550
+40,964
+61% +$418K ﹤0.01% 2910
2022
Q1 		$928K Buy
67,586
+1,935
+3% +$25.9K ﹤0.01% 2840
2021
Q4 		$836K Buy
65,651
+45,343
+223% +$645K ﹤0.01% 2916
2021
Q3 		$282K Buy
20,308
+7,886
+63% +$121K ﹤0.01% 3259
2021
Q2 		$219K Hold
12,422
– – ﹤0.01% 3240
2021
Q1 		$190K Buy
+12,422
New +$177K ﹤0.01% 3245

Other funds holding BVS

EWM
Essex Woodlands Management The Woodlands, Texas $254M AUM 4.59% 1-Year Est. Return
JIC
Juniper Investment Company New York $378M AUM 95.37% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RA
Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Nuveen's BVS Position: Q2 2026 in Review

Nuveen increased its Bioventus (BVS) stake by 14% in Q2 2026, buying an estimated $199K and bringing the position to 169,513 shares worth $1.6M. The position accounts for ﹤0.01% of the portfolio, ranked #2695.

Nuveen first reported a position in BVS in Q1 2021 and has held it in 16 quarters since. The position peaked at $21.3M in Q1 2025. 157 funds tracked by Wall St. Rank hold BVS as of Q2 2026.

  • Nuveen held 169,513 shares of Bioventus worth $1.6M as of Q2 2026.
  • Nuveen bought 20,851 Bioventus shares in Q2 2026, an estimated $199K.
  • Bioventus made up ﹤0.01% of Nuveen's portfolio in Q2 2026, its #2695 holding.
  • Nuveen first reported a position in Bioventus in Q1 2021 and has held it in 16 quarters since.
  • Nuveen's Bioventus position peaked at $21.3M in Q1 2025.
  • 157 funds tracked by Wall St. Rank held Bioventus as of Q2 2026.

Based on Nuveen's 13F filing for Q2 2026, filed 11 Aug 2026.